The presence of respiratory symptoms in Parkinson's disease (PD) has been known since the first description of the disease, even though the prevalence and incidence of these disturbances are not well defined. Several causes have been reported, comprising obstructive and restrictive pulmonary disease and changes in the central ventilatory control, and different pathogenetic mechanisms have been postulated accordingly. In our review, we encompass the current knowledge about respiratory abnormalities in PD, as well as the impact of anti-Parkinsonian drugs as either risk or protective factors. A description of putative pathogenetic mechanisms is also provided, and possible treatments are discussed, focusing on the importance of recognising and treating respiratory symptoms as a key manifestation of the disease itself. A brief description of respiratory dysfunctions in atypical Parkinsonism, especially α-synucleinopathies, is also provided.

Respiratory dysfunction in Parkinson's disease: a narrative review / A. D'Arrigo, S. Floro, F. Bartesaghi, C. Casellato, G.F. Sferrazza Papa, S. Centanni, A. Priori, T. Bocci. - In: ERJ OPEN RESEARCH. - ISSN 2312-0541. - 6:4(2020 Oct 05). [10.1183/23120541.00165-2020]

Respiratory dysfunction in Parkinson's disease: a narrative review

A. D'Arrigo
Primo
;
S. Floro
Secondo
;
F. Bartesaghi;C. Casellato;G.F. Sferrazza Papa;S. Centanni;A. Priori
Penultimo
;
T. Bocci
Ultimo
2020

Abstract

The presence of respiratory symptoms in Parkinson's disease (PD) has been known since the first description of the disease, even though the prevalence and incidence of these disturbances are not well defined. Several causes have been reported, comprising obstructive and restrictive pulmonary disease and changes in the central ventilatory control, and different pathogenetic mechanisms have been postulated accordingly. In our review, we encompass the current knowledge about respiratory abnormalities in PD, as well as the impact of anti-Parkinsonian drugs as either risk or protective factors. A description of putative pathogenetic mechanisms is also provided, and possible treatments are discussed, focusing on the importance of recognising and treating respiratory symptoms as a key manifestation of the disease itself. A brief description of respiratory dysfunctions in atypical Parkinsonism, especially α-synucleinopathies, is also provided.
Parkinson’ s disease; respiratory dysfunction
Settore MED/10 - Malattie dell'Apparato Respiratorio
Settore MED/26 - Neurologia
5-ott-2020
2020
Article (author)
File in questo prodotto:
File Dimensione Formato  
2020 Parkinson review ERJ open.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 483.65 kB
Formato Adobe PDF
483.65 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/777510
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 20
social impact